Abstract
RIBONUCLEASE inhibitor is a cytoplasmic protein that tightly binds and inhibits ribonucleases of the pancreatic ribonuclease super-family1. The primary sequence of this inhibitor contains leucine-rich repeats2 (LRRs); these motifs are present in many proteins that participate in protein–protein interactions and have different functions and cellular locations. In vivo, ribonuclease inhibitor may have a role in the regulation of RNA turnover in mammalian cells3 and in angiogenesis4. To define the structural features of LRR proteins and to understand better the nature of the tight interaction of ribonuclease inhibitor with ribonucleases, we have determined the crystal structure of the porcine inhibitor. To our knowledge, this is the first three-dimensional structure of a protein containing LRRs and represents a new class of α/β protein fold. Individual repeats constitute β–α structural units that probably also occur in other proteins containing LRRs. The non-globular shape of the structure and the exposed face of the parallel β-sheet may explain why LRRs are used to achieve strong protein–protein interactions. A possible ribonuclease-binding region incorporates the surface formed by the parallel β-sheet and the βα loops.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lee, F. S. & Vallee, B. L. Prog. Nucleic Acids Res. molec. Biol. 44, 1–30 (1993).
Hofsteenge, J. et al. Biochemistry 27, 8537–8544 (1988).
Quirin-Stricker, C., Gross, M. & Mandel, P. Biochim. biophys. Acta 159, 75–80 (1968).
Shapiro, R. & Vallee, B. L. Proc. natn. Acad. Sci. U.S.A. 84, 2238–2241 (1987).
Kabsch, W. & Sander, C. Biopolymers 22, 2577–2637 (1983).
Lasters, et al. Proc. natn. Acad. Sci. U.S.A. 85, 3338–3342 (1988).
Fominaya, J. M. & Hofsteenge, J. J. biol. Chem. 267, 24655–24660 (1992).
McFarland, K. C. et al. Science 245, 494–499 (1989).
Schneider, R. & Schweiger, M. Oncogene 6, 1807–1811 (1991).
Hashimoto, C., Hudson, K. L. & Anderson, K. V. Cell 52, 269–279 (1988).
Reinke, R. et al. Cell 52, 291–301 (1988).
Lopez, J. A. et al. Proc. natn. Acad. Sci. U.S.A. 84, 5615–5619 (1987).
Krusius, T. & Ruoslahti, E. Proc. natn. Acad. Sci. U.S.A. 83, 7683–7687 (1986).
Oldberg, Å et al. EMBO J. 8, 2601–2604 (1989).
Kataoka, T., Broek, D. & Wigler, M. Cell 43, 493–505 (1985).
Tan, F. et al. J. biol. Chem. 265, 13–19 (1990).
Leung, K. Y. & Straley, S. C. J. Bact. 171, 4623–4632 (1989).
Fresco, L. D., Harper, D. S. & Keene, J. D. Molec cell. Biol. 11, 1578–1589 (1991).
Schneider, R. & Schweiger, M. FEBS Lett. 283, 203–206 (1991).
Yoder, M. D., Keen, N. T. & Jurnak, F. Science 260, 1503–1507 (1993).
Young, D. et al. Proc. natn. Acad. Sci. U.S.A. 86, 7989–7993 (1989).
Vicentini, A. M. et al. Biochemistry 29, 8827–8834 (1990).
Lee, F. S. & Vallee, B. L. Proc. natn. Acad. Sci. U.S.A. 87, 1879–1883 (1990).
Lee, F. S. & Vallee, B. L. Biochemistry 29, 6633–6638 (1990).
Hofsteenge, J., Vincentini, A. & Stone, S. R. Biochem. J. 275, 541–543 (1991).
Hofsteenge, J., Servis, C. & Stone, S. R. J. biol. Chem. 266, 24198–24204 (1991).
Nicholls, A. & Honig, B. J. comp. Chem. 12, 435–445 (1991).
Kobe, B. & Deisenhofer, J. J. molec. Biol. 231, 137–140 (1993).
Neumann, U. et al. J. molec. Biol. 231, 505–508 (1993).
Hamlin, R. Meth. Enzym. 114, 416–452 (1985).
Howard, A. J., Nielsen, C. & Xuong, N. H. Meth. Enzym. 114, 452–472 (1985).
Steigemann, W. PROTEIN: A Program System for the Crystal Structure Analysis of Proteins (Max-Planck-lnstitut für Biochemie, Martinsried, Germany, 1992).
Bode, W. & Schirmer, T. Biol. Chem. Hoppe-Seyler 366, 287–295 (1985).
Wang, B.-C. Meth. Enzym. 115, 90–112 (1985).
Jones, T. A., Bergdoll, M. & Kjeldgaard, M. in Crystallographic and Modeling Methods in Molecular Design (eds Bugg, C. E. & Ealick, S. E.) 189–195 (Springer, New York, 1990).
Brünger, A. T., Kuriyan, J. & Karplus, M. Science 235, 458–460 (1987).
Luzzati, P. V. Acta crystallogr. 5, 802–810 (1952).
Read, R. J. Acta crystallogr. A42, 140–149 (1986).
Carson, M. J. molec. Graphics 5, 105–106 (1987).
Wilmot, C. M. & Thornton, J. M. Protein Engng 3, 479–493 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kobe, B., Deisenhofer, J. Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats. Nature 366, 751–756 (1993). https://doi.org/10.1038/366751a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/366751a0
This article is cited by
-
Large-scale analysis of the N-terminal regulatory elements of the kinase domain in plant Receptor-like kinase family
BMC Plant Biology (2024)
-
Ribonuclease inhibitor 1 (RNH1) deficiency cause congenital cataracts and global developmental delay with infection-induced psychomotor regression and anemia
European Journal of Human Genetics (2023)
-
Crystal structures of FNIP/FGxxFN motif-containing leucine-rich repeat proteins
Scientific Reports (2022)
-
Discovery of antitumor effects of leczymes
Glycoconjugate Journal (2022)
-
Subcellular localization of the mouse PRAMEL1 and PRAMEX1 reveals multifaceted roles in the nucleus and cytoplasm of germ cells during spermatogenesis
Cell & Bioscience (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.